Testing targeted anti-inflammatory drugs for severe pneumonia in the ICU
Part of Infections, Lungs & breathing clinical trials.
This trial tests if anti-inflammatory drugs tailored to specific germs can help patients in the ICU with severe community-acquired pneumonia recover faster. You may be eligible if you've been in the ICU less than 48 hours and meet certain diagnostic criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to the intensive care unit (ICU).
- You are 18 years or older.
- You have been in the ICU for 48 hours or less.
- You have a diagnosis of severe community-acquired pneumonia based on standard guidelines.
- You do not have pneumonia that started in the hospital or from a ventilator.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how severe pneumonia acquired outside of a hospital is currently treated, to better understand the illness and improve care. It may help researchers develop better ways to diagnose and manage this serious lung infection.
This trial tests whether combining certain antibiotics works better for severe pneumonia. It looks at patients who are very sick and need hospital care right away.
This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.
This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.
This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
Hear when a new Severe Community-acquired Pneumonia (sCAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.